 | 
|
| |
|
Titel: Definition av diastolisk hjärtsvikt (serie: Tema diastolisk hjärtsvikt) 2007 nr 34 sid 2333-7
|
Referenser:
1.Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22.
2.Ryden-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999;246:275-84.
3.Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.
4.Brutsaert DL, Sys SU, Gilbert TC. Diastolic failure: Pathophysiology and therapeutic implications. J Am Coll Cardiol 1993;22:318-325.
5.Brutsaert DL. Diagnosing primary diastolic heart failure. Eur Heart J 2000;21:94-6.
6.Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ 2000;321:215-8.
7.Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
8.Caruana L, Davie AP, Petrie M, McMurray J. Diagnosing heart failure. Eur Heart J 1999;20:393.
9.Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
10.Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo S, et al. Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-16.
11.Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
12.Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
13.Persson H, Lonn E, Edner M; Investigators of the CHARM Echocardiographic Substudy-CHARMES. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 2007;49:687-94. Epub 2007 Jan 26.
14.Binkley PF, Shaffer PB, Ryan JM, Leier CV. Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure. J Lab Clin Med 1989;3:266-71.
15.Monrad ES, McKay RG, Baim DS, Colucci WS, Fifer MA, Heller GV, et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984;6:1030-7.
16.Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of primary diastolic heart failure: an epidemiological perspective. J Am Coll Cardiol 1995;26:1565-74.
17.Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of primary diastolic heart failure: an epidemiological perspective. J Am Coll Cardiol 1995;26:1565-74.
18.Ramachandran S, Vasan RS, Levy D. Defining Diastolic Heart Failure: A Call for standarized Diagnostic Criteria. Circulation 2000;101:2118-21.
19.Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002;105:1195-201.
20.Anonymous. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003
21.ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: the executive summary. J Heart Lung Transplant 2002;21:189-203
22.Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. Eur Heart J 2007 Apr 11; [Epub ahead of print].
23.Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
24.Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community; a study of all incident cases in Olmstead County, Minnesota, in 1991. Circulation 1998;98:2282-9.
25.Jarnert C, Mejhert M, Ring M, Persson H, Edner M. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Eur J Heart Fail 2000;2:151-60.
26.Alehagen U, Lindstedt G, Eriksson H, Dahlström U. Utility of the aminoterminal fragment of pro-brain natriuretic peptide in plasma for evaluation of cardiac dysfunction in elderly patients in primary health care. Clin Chem 2003;49:13337-46.
27.Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, et al. Cardioac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Academ Sci USA 2000;97:4239-44.
28.Ogawa Y, Tamora N, Cusho H, Nakao K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 2001;79:723-9.
29.Dahlström U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004;6:281-7.
30.Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002;8:279-87.
 2333 |
 2334 |
 2335 |
 2336 |
 2337 |